|
|
Bios - Update on Natalizumab |
|
|
|
|
J. Theodore Phillips, Jr., MD, PhD Director, Multiple Sclerosis Center at Texas Neurology Clinical Associate Professor of Neurology University of Texas Southwestern Medical Center Ted Phillips, MD, is the director of the Multiple Sclerosis Center at Texas Neurology in Dallas. He serves as a clinical associate professor of neurology at the University of Texas Southwestern Medical Center and serves as an attending neurologist at Baylor University Medical Center in Dallas. Dr. Phillips is a graduate of the University of Texas at Austin with special honors in chemistry. He received his MD and his PhD in immunology and completed neurology residency training from the University of Texas Southwestern Medical Center at Dallas. He is a principal developer of a national registry for MS (MSTRAC) and is a principal investigator in several ongoing clinical treatment trials in MS. Robert Fox, MD Robert Fox, MD, received his undergraduate degree from Amherst College and his medical degree from Johns Hopkins University. He pursued residency training in neurology at the Hospital of the University of Pennsylvania in Philadelphia. He completed clinical training as a Potiker Fellow at the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic Foundation, where he now continues as a staff neurologist. He is also the director of the Mellen Center MS tissue donation program.
Igor J. Koralnik, MD Igor J. Koralnik, MD, is an associate professor of neurology at Harvard Medical School and director of the HIV/Neurology Center at Beth Israel Deaconess Medical Center. Dr. Koralnik earned his MD at the University of Geneva Medical School, and he held his internship and residency in internal medicine at Geneva University Hospital. Dr. Koralnik conducted his residency in neurology in the Harvard-Longwood Neurology Training Program at Harvard Medical School and a post-doctoral fellowship in molecular biology of retroviruses at the National Institutes of Health. With specialties in neuro-infectious diseases and neuroAIDS, Dr. Koralnik is the author of numerous peer-reviewed publications. The focus of Dr. Koralnik’s research program is progressive multifocal leukoencephalopathy and its etiologic agent, the polyomavirus JC. |
|
|